drugset

drugset / Trial / NCT00557583

Evaluation of Safety and Pharmacokinetics of Single Doses of VBY-376 in Healthy Adults

NCT00557583 ↗

Phase 1 Completed 48 enrolled Virobay Inc.

RandomizedSingle-groupTriple-blind

Summary

The study will evaluate the safety and pharmacokinetics of single doses of VBY-376 in healthy subjects.

Timeline

Start: 2007-11
Primary completion: 2008-02
Completion: 2008-02

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	VBY-376	Unknown	50 mg	—

Indications